中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
3期
158-161
,共4页
霍莉莉%李慧%魏枫%赵华%任秀宝
霍莉莉%李慧%魏楓%趙華%任秀寶
곽리리%리혜%위풍%조화%임수보
乳腺癌%FoxP3%TGF-β1%上皮间质转化
乳腺癌%FoxP3%TGF-β1%上皮間質轉化
유선암%FoxP3%TGF-β1%상피간질전화
breast cancer%FoxP3%TGF-β1%epithelial-mesenchymal transition
目的:探讨乳腺癌组织FoxP3、TGF-β1的表达和上皮间质转化(EMT)的相互关系及其临床意义。方法:免疫组织化学法检测74例乳腺癌组织中FoxP3、TGF-β1、E-Cadherin、N-Cadherin、Vimentin和Fibronectin的表达情况,分析乳腺癌FoxP3蛋白表达与临床病理特征的关系,以及FoxP3、TGF-β1的表达和EMT发生之间的关系。结果:FoxP3与TGF-β1的表达率和EMT的发生率分别为36.5%(27/74)、39.2%(29/74)和40.5%(30/74)。乳腺癌FoxP3表达与淋巴结转移相关(P<0.05),与其他临床病理特征无关(P>0.05)。FoxP3和TGF-β1的表达之间存在相关性,而TGF-β1可以促进EMT发生(P<0.05)。结论:FoxP3的表达与乳腺癌淋巴结转移和EMT的发生相关,可能作为预测乳腺癌转移可能性的标记物。
目的:探討乳腺癌組織FoxP3、TGF-β1的錶達和上皮間質轉化(EMT)的相互關繫及其臨床意義。方法:免疫組織化學法檢測74例乳腺癌組織中FoxP3、TGF-β1、E-Cadherin、N-Cadherin、Vimentin和Fibronectin的錶達情況,分析乳腺癌FoxP3蛋白錶達與臨床病理特徵的關繫,以及FoxP3、TGF-β1的錶達和EMT髮生之間的關繫。結果:FoxP3與TGF-β1的錶達率和EMT的髮生率分彆為36.5%(27/74)、39.2%(29/74)和40.5%(30/74)。乳腺癌FoxP3錶達與淋巴結轉移相關(P<0.05),與其他臨床病理特徵無關(P>0.05)。FoxP3和TGF-β1的錶達之間存在相關性,而TGF-β1可以促進EMT髮生(P<0.05)。結論:FoxP3的錶達與乳腺癌淋巴結轉移和EMT的髮生相關,可能作為預測乳腺癌轉移可能性的標記物。
목적:탐토유선암조직FoxP3、TGF-β1적표체화상피간질전화(EMT)적상호관계급기림상의의。방법:면역조직화학법검측74례유선암조직중FoxP3、TGF-β1、E-Cadherin、N-Cadherin、Vimentin화Fibronectin적표체정황,분석유선암FoxP3단백표체여림상병리특정적관계,이급FoxP3、TGF-β1적표체화EMT발생지간적관계。결과:FoxP3여TGF-β1적표체솔화EMT적발생솔분별위36.5%(27/74)、39.2%(29/74)화40.5%(30/74)。유선암FoxP3표체여림파결전이상관(P<0.05),여기타림상병리특정무관(P>0.05)。FoxP3화TGF-β1적표체지간존재상관성,이TGF-β1가이촉진EMT발생(P<0.05)。결론:FoxP3적표체여유선암림파결전이화EMT적발생상관,가능작위예측유선암전이가능성적표기물。
Objective: This study aims to investigate the correlation between the expression of FoxP3, TGF-β1, and epitheli-al-mesenchymal transition (EMT) in breast cancer and to determine the clinical significance of FoxP3. Methods: The expression of FoxP3, TGF-β1, E-Cadherin, N-Cadherin, Vimentin, and Fibronectin protein were detected in the cancer cells of 74 cases with breast carcinoma via immunohistochemistry. The correlation of FoxP3 protein with clinico-pathologic features of breast carcinoma and the re-lationships among the expressions of FoxP3, TGF-β1, and epithelial-mesenchymal transition (EMT) were analyzed. Results:The ex-pression rates of FoxP3, TGF-β1, and EMT are 36.5%(27/74), 39.2%(29/74), and 40.5%(30/74), respectively. The FoxP3 protein ex-pression in breast cancer is correlated with lymph node metastasis (P<0.05) but not with other clinico-pathological features (P>0.05). The expression of FoxP3 is also correlated with the expression of TGF-β1. Furthermore, TGF-β1 can induce EMT (P<0.05). Conclu-sion:The expression of FoxP3 is correlated with lymph node metastasis and EMT in breast cancer. Therefore, FoxP3 may be a marker for predicting metastasis.